- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02737111
Families' Experiences of Paediatric ICC Diagnosis (FEPICCD)
How do Families Experience Receiving a Positive Diagnosis for an Inherited Cardiac Condition for a Child? The Experiences of Children With a Diagnosis, Their Parents and Siblings.
This study aims to further understand the experiences of children, their parents and siblings around the time when the child and their family are informed of a diagnosis of an inherited cardiac condition (ICC). The researchers are interested to understand how families experience the process of receiving a diagnosis of an ICC, and explore experiences from multiple perspectives within the family (i.e. parents, children and siblings).
The Primary Project Objective:
How do children, their parents and siblings experience the communication of a diagnosis of an inherited cardiac condition (ICC)? What is found to be helpful and less helpful?
The Secondary Project Objective:
To explore qualitatively how families experience the communication of a positive diagnosis for an inherited cardiac condition for a child and will seek the perspectives of the child with the diagnosis, their siblings and parents.
Study Overview
Status
Conditions
Detailed Description
Background Information and Study Rationale:
An ICC comprise of a number of conditions that affect either the heart muscle (cardiomyopathies), or the electrical circuits of the heart (ion channelopathies). ICCs can result in the heart working ineffectively, dangerous arrhythmias and sudden death. The last decade has seen dramatic advances in understanding of the pathology of ICCs. More than 50 ICCs have been recognised and genetics tests are increasingly available. Epidemiological evidence suggests a combined total prevalence for ICCs of about 340,000 in the UK.
In response to advances in medical and genetic understanding of ICCs, ICC services have also grown dramatically, accompanied by commissiioning guidelines, and when an ICC is diagnosed there are implications not only for the patient themselves but for relatives. For families affected by inherited cardiac conditions, the layers of impact can be complex. When a child receives a positive diagnosis there can be implications for parents and siblings not only of living with the child's diagnosis, but also for one's own health and wellbeing. This can lead to uncertainty about the health of others in the family and subsequent medical investigates.
To the researchers' knowledge, there is little published evidence which aims to understand the experiences of children and their siblings of the communication around their ICC condition. Therefore ICC services risk of relying on our own clinical intuition or the views of parents rather than hearing directly from children and young people themselves. This present study therefore proposed to explore qualitatively how families experience the communication of a positive diagnosis for an inherited cardiac condition for a child and will seek the perspectives of the child with the diagnosis, their siblings and parents.
Participants will be recruited from a ICC service at an NHS Hospital in London. Paedaitric patients (who have been given an ICC diagnosis) and their siblings will be aged 8-16, and their Parents. Patient recruitment at a site will only commence once the trial team has ensured that the following approval/essential documents are in place:
- The main REC approval,
- Final sponsorship and/or R&D approval (NHS Permission),
- Local Site Delegation of Duties and Signature Log is completed.
All subjects who wish to enter the study will be fully screened and consented by the Chief Investigator (CI), or one of the qualified clinicians involved in the study as the Researchers.
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Children aged 8 - 16 who have received a positive diagnosis of an inherited cardiac condition from the ICC service at the hospital within the last 3 months, their parents and siblings.
- Siblings of children who have received a diagnosis of an inherited cardiac condition who are between the ages of 8 and 16 years.
- Children will only participate if they are already aware of their diagnosis or their sibling's diagnosis.
- Children will only participate if they and a parent/person with parental responsibility have both consented to take part.
- Parents will only take part if they have given informed consent
Exclusion Criteria:
1. Children who are unable to communicate verbally will not be included in the research as they would be unable to consent to their involvement in the research and alternative means of data collection would be required.
Discontinuation/ withdrawal of Pariticpants and Stopping Rules:
Participants can withdraw their participation from the study at any time without giving a reason and if this happens, the data collected from their interviews/questionnaires will not be used in the study results. Adult participants will be told that they can tell the researcher if they would like to withdraw. The researcher will agree a word or sign with child participants to indicate that they would like to stop taking part and the researcher will then ask them whether they would like the data used to be included in the results of the study.
The researcher will continue to recruit participants until there is sufficient data for qualitative analysis of interviews.
It is unlikely that the study will be stopped prematurely but this might occur if insufficient numbers of participants are able to be recruited from one or more of the patient samples (i.e. children with a diagnosis, parents or siblings) in the designated time frame.
Study Plan
How is the study designed?
Design Details
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Experience of recieving a diagnosis of an ICC.
Time Frame: Interviews will occur within 2-3 months of recieiving the diagnosis
|
Semi-structured interviews (Child, Sibling and Parent version) will be transcriped and analysed using thematic analysis, whereby common themes will be identified within and between participant interviews.
Thematic analysis is a method for identifying, analysing and reporting patterns (themes) within data.
Thematic analysis is a way to organise and describe a data set from qualitative interviews in rich detail.
|
Interviews will occur within 2-3 months of recieiving the diagnosis
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Jan Till, Doctor, Royal Brompton & Harefield NHS Foundation Trust
Study record dates
Study Major Dates
Study Start
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Estimate)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2015PC002B
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
IPD Plan Description
All adult participants will be invited to a presentation of the research findings and will be given the option of receiving a final summary of the research findings once the study has been written up for publication.
All child participants will also be invited to attend a separate presentation of the findings and will be offered a child friendly summary of the results. The researcher will provide a contact email address should participants have any further questions regarding the study and/or results.
A report of the analysis will be written and a selection of anonymised quotations/extracts demonstrating each theme will be selected to accompany the report.
It is intended that the research will be published in a peer-reviewed journal.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Inherited Cardiac Conditions
-
Manchester University NHS Foundation TrustWithdrawn
-
Imperial College LondonRoyal Brompton & Harefield NHS Foundation Trust; Great Ormond Street Hospital...RecruitingCardiovascular Diseases | Inherited Cardiac ConditionsUnited Kingdom
-
UMC UtrechtRadboud University Medical Center; University Medical Center Groningen; Amsterdam...RecruitingInherited Cardiac DiseaseNetherlands
-
Johns Hopkins UniversityNational Human Genome Research Institute (NHGRI)Active, not recruitingGenetic Counseling | Inherited Cardiac DiseaseUnited States
-
King's College LondonKing's College Hospital NHS Trust; Guy's and St Thomas' NHS Foundation Trust; National Institute for Health Research, United KingdomSuspendedCardiomyopathies | Inherited Cardiac Conduction DisorderUnited Kingdom
-
University of LeicesterNot yet recruitingVentricular Fibrillation | Ventricular Arrhythmia | Sudden Cardiac Arrest | Athlete | Inherited Cardiac ConditionsUnited Kingdom
-
Children's Hospital of Eastern OntarioHeart and Stroke Foundation of Ontario; Variety Village; City of Toronto Parks...CompletedCardiomyopathy | Congenital Heart Defects | Inherited Cardiac ArrhythmiasCanada
-
Nantes University HospitalTerminatedInherited Arrhythmias and ValvulopathiesFrance
-
University Hospital, MontpellierInstitut National de la Santé Et de la Recherche Médicale, FranceCompletedPediatric ALL | Long QT Syndrome | Inherited Cardiac Conduction Disorder | Congenital Long Qt SyndromeFrance
-
Erasmus Medical CenterRecruiting
Clinical Trials on Initial Screening Process
-
Institute of Tropical Medicine, BelgiumEcole Nationale de Santé Publique, Rabat, MoroccoCompletedGestational Diabetes Mellitus in PregnancyMorocco
-
Hackensack Meridian HealthBecton, Dickinson and CompanyCompleted
-
ASP 7 RagusaNot yet recruitingMultiple Sclerosis | Urinary Bladder, NeurogenicItaly
-
The University of Hong KongInnovation and Technology Commission, Hong KongNot yet recruitingChronic Fatigue Syndrome (CFS) | Post-COVID ME/CFSHong Kong
-
Xuelin YangChina Medical Board (CMB); Yichang Center for Disease Control and Prevention... and other collaboratorsRecruiting
-
Seung-Jung ParkCardioVascular Research Foundation, KoreaNot yet recruiting
-
University of MinnesotaTerminatedCardiac Arrest Due to Underlying Cardiac Condition | Ventricular Fibrillation | Cardiopulmonary Arrest With Successful ResuscitationUnited States, Canada
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruiting
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)Active, not recruitingFrailty | Aging | Surgery | Health Care UtilizationUnited States
-
Shanghai Jiao Tong University School of MedicineCompleted